by Instem Team | Aug 27, 2026 | BioRails, Study Management
For many years, Oracle databases have served as the foundation for scientific data management platforms across pharmaceutical, biotechnology, CRO, and research organizations. Their reliability, scalability, and enterprise-grade capabilities made them a natural choice...
by Instem Team | Aug 14, 2026 | In Silico & Data Insights, In Silico Insider, Leadscope
Applicability domain gives a prediction context A (Quantitative) Structure-Activity Relationship (Q)SAR result needs context before it can support a regulatory conclusion. For mutagenicity assessment under ICH M7, one part of that context is the applicability domain...
by Instem Team | Aug 13, 2026 | Compliance Builder, Study Management
For many quality and compliance teams, a regulatory inspection triggers a familiar and disruptive pattern. Skilled personnel find themselves pulled away from their usual responsibilities to search for the correct version of a file, compile audit trails from multiple...
by Instem Team | Aug 12, 2026 | Clinical
In clinical trial transparency, the terminology used in processes and reports is critical and can have significant downstream regulatory effects. The language used in an anonymization report influences how reviewers understand the strategy, how consistently teams...
by Instem Team | Aug 11, 2026 | Resources
Thornton & Ross Ltd was struggling to organize and collate large, diverse, and increasing volumes of laboratory test data to the point that these volumes were overwhelming their existing workflows. As the UK’s largest pharmaceutical manufacturer, it was imperative...
